LAS VEGAS (MAY 21, 2019) - Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of ...
LAS VEGAS, NV—Vascular closure complications occur in about one-quarter of patients undergoing transfemoral TAVR, according to post hoc analysis of the BRAVO 3 trial, but not all closure devices ...
Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...
Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback